Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Cheng D et al. | A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG. | 2011 | Curr Radiopharm | pmid:22191610 |
Nasir A et al. | Management of iron deficiency anaemia in gynaecological patients at Jinnah Postgraduate Medical Centre, Karachi. | 2011 | J Pak Med Assoc | pmid:22356035 |
Agarwal R et al. | Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial. | 2011 | Clin J Am Soc Nephrol | pmid:20876669 |
Auerbach M | Should intravenous iron be upfront therapy for iron deficiency anemia? | 2011 | Pediatr Blood Cancer | pmid:21298731 |
Crary SE et al. | Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. | 2011 | Pediatr Blood Cancer | pmid:21298748 |
Ibert M et al. | Evidence of benzilic rearrangement during the electrochemical oxidation of D-glucose to D-glucaric acid. | 2011 | Carbohydr. Res. | pmid:21269605 |
Vanderford NL | The role of MafA in regulating cytokine expression in pancreatic beta cells. | 2011 | J. Biol. Chem. | pmid:21239506 |
Fenwick S and Peebles G | Total dose infusion of intravenous iron in patients with chronic kidney disease receiving haemodialysis. | 2011 | J Ren Care | pmid:21288317 |
Pai AB et al. | Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose. | 2011 | Biometals | pmid:21229380 |
Malovrh M et al. | The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents. | 2011 | Artif Organs | pmid:20618233 |